PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 194 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,689,731 | -26.7% | 55,076 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $2,303,985 | +24.2% | 57,499 | +26.5% | 0.00% | 0.0% |
| Q1 2023 | $1,854,570 | +3.1% | 45,444 | -2.5% | 0.00% | 0.0% |
| Q4 2022 | $1,799,072 | -32.0% | 46,596 | -4.6% | 0.00% | -25.0% |
| Q3 2022 | $2,647,000 | -7.4% | 48,846 | +0.2% | 0.00% | -20.0% |
| Q2 2022 | $2,858,000 | -23.3% | 48,754 | -0.2% | 0.01% | 0.0% |
| Q1 2022 | $3,728,000 | +33.9% | 48,837 | -0.9% | 0.01% | +66.7% |
| Q4 2021 | $2,784,000 | +3.3% | 49,303 | +2.3% | 0.00% | -25.0% |
| Q3 2021 | $2,696,000 | -8.4% | 48,184 | -0.7% | 0.00% | 0.0% |
| Q2 2021 | $2,944,000 | -17.8% | 48,511 | -5.0% | 0.00% | -20.0% |
| Q1 2021 | $3,580,000 | +18.7% | 51,072 | +1.3% | 0.01% | 0.0% |
| Q4 2020 | $3,015,000 | -0.4% | 50,396 | +0.1% | 0.01% | -16.7% |
| Q3 2020 | $3,027,000 | -64.2% | 50,347 | -68.7% | 0.01% | -62.5% |
| Q2 2020 | $8,451,000 | +70.2% | 161,067 | +8.8% | 0.02% | +45.5% |
| Q1 2020 | $4,964,000 | -29.2% | 148,037 | -4.3% | 0.01% | +10.0% |
| Q4 2019 | $7,007,000 | +22.1% | 154,675 | +2.6% | 0.01% | +11.1% |
| Q3 2019 | $5,738,000 | +2581.3% | 150,724 | +2956.0% | 0.01% | – |
| Q2 2019 | $214,000 | -92.0% | 4,932 | -93.0% | 0.00% | -100.0% |
| Q1 2019 | $2,684,000 | -15.5% | 70,509 | -4.4% | 0.00% | -33.3% |
| Q4 2018 | $3,175,000 | -17.5% | 73,789 | -5.7% | 0.01% | 0.0% |
| Q3 2018 | $3,847,000 | +442.6% | 78,284 | +485.3% | 0.01% | +500.0% |
| Q1 2016 | $709,000 | +146.2% | 13,376 | +257.2% | 0.00% | 0.0% |
| Q4 2015 | $288,000 | +8.7% | 3,745 | 0.0% | 0.00% | – |
| Q2 2015 | $265,000 | -20.4% | 3,745 | 0.0% | 0.00% | -100.0% |
| Q1 2015 | $333,000 | -4.9% | 3,745 | -5.1% | 0.00% | 0.0% |
| Q4 2014 | $350,000 | -8.4% | 3,945 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $382,000 | -44.5% | 3,945 | -47.3% | 0.00% | 0.0% |
| Q2 2014 | $688,000 | +187.9% | 7,490 | +119.3% | 0.00% | – |
| Q1 2014 | $239,000 | – | 3,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |